Why is weight loss different when you combine HRT and GLP-1s

Frustratingly, weight loss becomes noticeably more difficult during perimenopause and menopause. Hormonal changes during midlife can influence metabolism, body composition, and appetite in ways that make strategies that once worked feel less effective.

You may have heard about GLP-1 medications, like Ozempic or Wegovy, which were originally developed for diabetes and now being used for weight loss. In addition, you may have already learned that hormone therapy is commonly used to help relieve menopause symptoms like hot flashes and sleep disruption. Researchers are now exploring how GLP-1 medications and hormone therapy may work together to support weight management during menopause.

To understand why these therapies may work synergistically and may lead to enhanced effectiveness of GLP1 agonists, it helps to first look at how they work individually when used in perimenopause/menopause.

Why Weight Changes During Perimenopause and Menopause

When estrogen levels begin to decline during perimenopause and menopause, the body changes how it stores fat, regulates insulin, and uses energy. Before midlife, estrogen encourages fat to be stored more often in the hips and thighs. As estrogen levels fall, however, the body becomes more likely to store fat in the abdominal area.

Visceral adipose tissue, a component of abdominal fat, is metabolically active and produces inflammatory signals that are associated with reduced insulin sensitivity. Over time, this can affect how the body processes glucose and responds to insulin.

Muscle mass also gradually declines with age. After women reach their forties, they may lose about 3–8% of muscle mass per decade, and this process can accelerate after menopause. Because muscle tissue plays a major role in daily energy expenditure, even modest losses of learn muscle mass can influence how many calories the body uses at rest. When the body uses less energy, weight gain becomes more likely.

How Hormone Replacement Therapy Impacts Weight and Metabolism

By restoring some of the estrogen that declines during perimenopause/menopause, hormone therapy may influence some of the metabolic changes described above. Studies suggest that hormone therapy does not cause weight loss on its own. Instead, hormone regimens that include estrogens tend to impact how weight is distributed in the body and how sensitive the body is to insulin. Women using hormone therapy often have less fat accumulating in the abdominal area and better insulin sensitivity compared with women who do not use hormone therapy. These changes are associated with a healthier overall metabolism.

Additionally, relief from commonly occurring menopause symptoms such as sleep disruption and hot flashes may make it easier for some women to maintain the daily habits that support weight maintenance, including regular exercise and healthy sleep patterns.

GLP-1 Medications: How They Support Weight Loss

GLP-1 medications, such as semaglutide (Wegovy) and tirzepatide (Zepbound), were originally developed to treat type 2 diabetes and are now often used for chronic weight management.

These medications work by mimicking hormones that affect appetite, digestion, and blood sugar. In the pancreas, GLP-1s improve how the body regulates glucose by stimulating beta cells to produce insulin in response to high blood sugar. In the central nervous system, GLP-1s act on receptors in the hypothalamus that control hunger, resulting in increased feelings of fullness and decreased cravings. They also slow down how quickly the stomach empties after meals, reducing the appetite between meals.

Wegovy® Pen

Starting at $199 $499

(30 days of treatment)

Weekly injection. Average weight loss is 15% of body weight in 12 months*

Start Now

Together, these effects help reduce overall calorie intake and support weight loss for many people.

What Happens When Hormone Therapy and GLP-1 Medications Are Used Together

Emerging research suggests that the combination of hormone therapy with GLP-1 medications may lead to greater weight loss in menopausal women compared with GLP-1 therapy alone.

Each of these therapies targets different biological drivers of weight gain that occur during perimenopause and into menopause. Hormone therapy helps address some of the metabolic changes associated with declining estrogen, while GLP-1 medications primarily work by regulating appetite, digestion, and glucose metabolism.

While research on this combined approach is still developing, these findings suggest that by acting on these different pathways simultaneously, the two treatments may complement one another.

“The use of menopause hormone treatment to alleviate night sweats that results in less disruptive sleep has helped many women with increased energy and less fatigue. These improvements can help women to engage in the lifestyle habits that can support sustained weight loss, like the ability to increase physical activity. When women start on Menopause Hormone Treatment, alleviation of vasomotor symptoms and improved sleep can occur within days of initiation.” - Dr. Culver   

Supportive Lifestyle Strategies

GLP-1 agonists tend to work best when they are supported by healthy lifestyle habits. Nutrition, physical activity, and sleep all impact how the body uses energy during menopause.

Adequate protein intake and regular strength training are especially important during midlife because they help preserve muscle mass. Maintaining muscle helps the body use energy more efficiently throughout the day. Fiber-rich foods, balanced meals, and regular physical activity  can also help regulate blood sugar and appetite.

Getting enough restful sleep and maintaining positive daily routines can help balance the hormonal systems that influence appetite, energy levels, and long-term patterns of weight change.

What to Discuss with Your Healthcare Provider

If you are considering hormone therapy, GLP-1 medications, or both, it is important to have a conversation with your healthcare provider. To advise you of the recommended and appropriate treatment, your health care provider will need information about your cardiovascular risk factors, history of blood clots, current medications, and general fitness, among other health histories. 

During your visit with your health care provider, you may want to discuss the type and route of hormone therapy that might be best for you, and how GLP-1 medications fit into your personal approach to weight loss. Both types of medications require monitoring and follow-up to ensure that they are effective,safe, and that any needed adjustments are made as your needs and health may change over time.  

Frequently Asked Questions

How do hormonal changes during menopause specifically contribute to weight gain?

Declining estrogen levels cause the body to shift fat storage from the hips and thighs to the abdominal area. This abdominal fat is metabolically active and produces inflammatory signals that can reduce insulin sensitivity and affect how the body processes glucose. Additionally, women in midlife experience a gradual decline in muscle mass which can accelerate after menopause. Since muscle tissue is vital for daily energy expenditure, losing it reduces the number of calories the body burns at rest and makes weight gain more likely.

What are the benefits of combining hormone therapy with GLP-1 medications?

Combining these treatments may result in greater weight loss for menopausal women than using GLP-1 therapy alone because the two approaches target different biological drivers. Hormone therapy addresses metabolic changes and fat distribution linked to estrogen loss while also improving sleep and energy by reducing night sweats and hot flashes. Meanwhile, GLP-1 medications focus on regulating appetite, slowing digestion, and improving glucose metabolism. By acting on these various pathways simultaneously, the treatments complement each other and can make it easier to maintain the lifestyle habits necessary for sustained weight loss.

How do GLP-1 medications assist with chronic weight management?

GLP-1 medications mimic hormones that impact the central nervous system, the pancreas, and the digestive system. In the hypothalamus, they act on receptors that control hunger to increase feelings of fullness and decrease cravings. In the pancreas, they stimulate beta cells to produce insulin in response to high blood sugar to better regulate glucose. They also slow the rate at which the stomach empties after meals. These combined effects help individuals reduce their overall calorie intake and support significant weight loss.